nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—NFKB1—primary biliary cirrhosis	0.558	1	CbGaD
Thalidomide—CYP2E1—Ursodeoxycholic acid—primary biliary cirrhosis	0.0943	0.485	CbGbCtD
Thalidomide—CYP2E1—Colchicine—primary biliary cirrhosis	0.0659	0.339	CbGbCtD
Thalidomide—CYP2C9—Colchicine—primary biliary cirrhosis	0.0344	0.177	CbGbCtD
Thalidomide—Lenalidomide—CDH5—primary biliary cirrhosis	0.00629	1	CrCbGaD
Thalidomide—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000424	0.003	CcSEcCtD
Thalidomide—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000412	0.00291	CcSEcCtD
Thalidomide—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000412	0.00291	CcSEcCtD
Thalidomide—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.000409	0.00289	CcSEcCtD
Thalidomide—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.000409	0.00289	CcSEcCtD
Thalidomide—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000406	0.00287	CcSEcCtD
Thalidomide—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000406	0.00287	CcSEcCtD
Thalidomide—Pancytopenia—Colchicine—primary biliary cirrhosis	0.000401	0.00284	CcSEcCtD
Thalidomide—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000401	0.00284	CcSEcCtD
Thalidomide—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000401	0.00284	CcSEcCtD
Thalidomide—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000397	0.00281	CcSEcCtD
Thalidomide—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000397	0.00281	CcSEcCtD
Thalidomide—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.000396	0.0028	CcSEcCtD
Thalidomide—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000396	0.0028	CcSEcCtD
Thalidomide—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000396	0.0028	CcSEcCtD
Thalidomide—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.000396	0.0028	CcSEcCtD
Thalidomide—Neutropenia—Colchicine—primary biliary cirrhosis	0.000395	0.00279	CcSEcCtD
Thalidomide—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00274	CcSEcCtD
Thalidomide—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00274	CcSEcCtD
Thalidomide—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00268	CcSEcCtD
Thalidomide—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00268	CcSEcCtD
Thalidomide—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00268	CcSEcCtD
Thalidomide—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00268	CcSEcCtD
Thalidomide—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000372	0.00263	CcSEcCtD
Thalidomide—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000372	0.00263	CcSEcCtD
Thalidomide—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.00037	0.00261	CcSEcCtD
Thalidomide—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.00037	0.00261	CcSEcCtD
Thalidomide—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.000369	0.00261	CcSEcCtD
Thalidomide—Stomatitis—Colchicine—primary biliary cirrhosis	0.000367	0.0026	CcSEcCtD
Thalidomide—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000365	0.00258	CcSEcCtD
Thalidomide—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000365	0.00258	CcSEcCtD
Thalidomide—Haematuria—Colchicine—primary biliary cirrhosis	0.000359	0.00254	CcSEcCtD
Thalidomide—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000353	0.00249	CcSEcCtD
Thalidomide—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000353	0.00249	CcSEcCtD
Thalidomide—Agranulocytosis—Colchicine—primary biliary cirrhosis	0.000352	0.00248	CcSEcCtD
Thalidomide—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000351	0.00248	CcSEcCtD
Thalidomide—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000351	0.00248	CcSEcCtD
Thalidomide—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00245	CcSEcCtD
Thalidomide—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00245	CcSEcCtD
Thalidomide—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000346	0.00244	CcSEcCtD
Thalidomide—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000346	0.00244	CcSEcCtD
Thalidomide—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000344	0.00243	CcSEcCtD
Thalidomide—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000344	0.00243	CcSEcCtD
Thalidomide—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000341	0.00241	CcSEcCtD
Thalidomide—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000341	0.00241	CcSEcCtD
Thalidomide—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000339	0.00239	CcSEcCtD
Thalidomide—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000339	0.00239	CcSEcCtD
Thalidomide—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000339	0.00239	CcSEcCtD
Thalidomide—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000339	0.00239	CcSEcCtD
Thalidomide—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.000338	0.00239	CcSEcCtD
Thalidomide—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.000338	0.00239	CcSEcCtD
Thalidomide—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.000337	0.00238	CcSEcCtD
Thalidomide—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000334	0.00236	CcSEcCtD
Thalidomide—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000334	0.00236	CcSEcCtD
Thalidomide—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000333	0.00235	CcSEcCtD
Thalidomide—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000333	0.00235	CcSEcCtD
Thalidomide—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00235	CcSEcCtD
Thalidomide—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00235	CcSEcCtD
Thalidomide—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000329	0.00233	CcSEcCtD
Thalidomide—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000329	0.00233	CcSEcCtD
Thalidomide—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.000325	0.00229	CcSEcCtD
Thalidomide—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.000325	0.00229	CcSEcCtD
Thalidomide—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000323	0.00228	CcSEcCtD
Thalidomide—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000323	0.00228	CcSEcCtD
Thalidomide—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00226	CcSEcCtD
Thalidomide—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00226	CcSEcCtD
Thalidomide—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00224	CcSEcCtD
Thalidomide—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00224	CcSEcCtD
Thalidomide—Eye disorder—Colchicine—primary biliary cirrhosis	0.000316	0.00223	CcSEcCtD
Thalidomide—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000305	0.00215	CcSEcCtD
Thalidomide—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00215	CcSEcCtD
Thalidomide—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00215	CcSEcCtD
Thalidomide—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000302	0.00213	CcSEcCtD
Thalidomide—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000302	0.00213	CcSEcCtD
Thalidomide—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00212	CcSEcCtD
Thalidomide—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00212	CcSEcCtD
Thalidomide—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000299	0.00212	CcSEcCtD
Thalidomide—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000299	0.00212	CcSEcCtD
Thalidomide—Alopecia—Colchicine—primary biliary cirrhosis	0.000299	0.00211	CcSEcCtD
Thalidomide—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000298	0.00211	CcSEcCtD
Thalidomide—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000298	0.00211	CcSEcCtD
Thalidomide—Malnutrition—Colchicine—primary biliary cirrhosis	0.000295	0.00208	CcSEcCtD
Thalidomide—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000293	0.00207	CcSEcCtD
Thalidomide—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000293	0.00207	CcSEcCtD
Thalidomide—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000284	0.00201	CcSEcCtD
Thalidomide—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000284	0.00201	CcSEcCtD
Thalidomide—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000283	0.002	CcSEcCtD
Thalidomide—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000283	0.002	CcSEcCtD
Thalidomide—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000283	0.002	CcSEcCtD
Thalidomide—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000282	0.00199	CcSEcCtD
Thalidomide—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000282	0.00199	CcSEcCtD
Thalidomide—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000276	0.00195	CcSEcCtD
Thalidomide—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000276	0.00195	CcSEcCtD
Thalidomide—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00194	CcSEcCtD
Thalidomide—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00194	CcSEcCtD
Thalidomide—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000274	0.00194	CcSEcCtD
Thalidomide—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000274	0.00194	CcSEcCtD
Thalidomide—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000273	0.00193	CcSEcCtD
Thalidomide—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000273	0.00193	CcSEcCtD
Thalidomide—Anaemia—Colchicine—primary biliary cirrhosis	0.000272	0.00192	CcSEcCtD
Thalidomide—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000272	0.00192	CcSEcCtD
Thalidomide—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000272	0.00192	CcSEcCtD
Thalidomide—Angioedema—Colchicine—primary biliary cirrhosis	0.000269	0.0019	CcSEcCtD
Thalidomide—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000269	0.0019	CcSEcCtD
Thalidomide—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000269	0.0019	CcSEcCtD
Thalidomide—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000265	0.00187	CcSEcCtD
Thalidomide—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000265	0.00187	CcSEcCtD
Thalidomide—Leukopenia—Colchicine—primary biliary cirrhosis	0.000264	0.00186	CcSEcCtD
Thalidomide—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000261	0.00184	CcSEcCtD
Thalidomide—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000261	0.00184	CcSEcCtD
Thalidomide—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00026	0.00183	CcSEcCtD
Thalidomide—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00026	0.00183	CcSEcCtD
Thalidomide—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000257	0.00182	CcSEcCtD
Thalidomide—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000257	0.00182	CcSEcCtD
Thalidomide—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00181	CcSEcCtD
Thalidomide—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00181	CcSEcCtD
Thalidomide—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000254	0.0018	CcSEcCtD
Thalidomide—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000254	0.0018	CcSEcCtD
Thalidomide—Arthralgia—Colchicine—primary biliary cirrhosis	0.000251	0.00177	CcSEcCtD
Thalidomide—Myalgia—Colchicine—primary biliary cirrhosis	0.000251	0.00177	CcSEcCtD
Thalidomide—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000246	0.00173	CcSEcCtD
Thalidomide—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000246	0.00173	CcSEcCtD
Thalidomide—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00173	CcSEcCtD
Thalidomide—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00173	CcSEcCtD
Thalidomide—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00171	CcSEcCtD
Thalidomide—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00171	CcSEcCtD
Thalidomide—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000239	0.00169	CcSEcCtD
Thalidomide—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000239	0.00169	CcSEcCtD
Thalidomide—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000238	0.00168	CcSEcCtD
Thalidomide—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000238	0.00168	CcSEcCtD
Thalidomide—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000237	0.00168	CcSEcCtD
Thalidomide—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000237	0.00168	CcSEcCtD
Thalidomide—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000237	0.00167	CcSEcCtD
Thalidomide—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000237	0.00167	CcSEcCtD
Thalidomide—Shock—Colchicine—primary biliary cirrhosis	0.000236	0.00167	CcSEcCtD
Thalidomide—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000236	0.00167	CcSEcCtD
Thalidomide—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000235	0.00166	CcSEcCtD
Thalidomide—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.000234	0.00165	CcSEcCtD
Thalidomide—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.000234	0.00165	CcSEcCtD
Thalidomide—Skin disorder—Colchicine—primary biliary cirrhosis	0.000233	0.00165	CcSEcCtD
Thalidomide—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000233	0.00164	CcSEcCtD
Thalidomide—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000233	0.00164	CcSEcCtD
Thalidomide—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000231	0.00163	CcSEcCtD
Thalidomide—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000231	0.00163	CcSEcCtD
Thalidomide—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000229	0.00162	CcSEcCtD
Thalidomide—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000229	0.00162	CcSEcCtD
Thalidomide—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000228	0.00161	CcSEcCtD
Thalidomide—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000228	0.00161	CcSEcCtD
Thalidomide—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000225	0.00159	CcSEcCtD
Thalidomide—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000225	0.00159	CcSEcCtD
Thalidomide—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000225	0.00159	CcSEcCtD
Thalidomide—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000225	0.00159	CcSEcCtD
Thalidomide—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000225	0.00159	CcSEcCtD
Thalidomide—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000225	0.00159	CcSEcCtD
Thalidomide—Hypotension—Colchicine—primary biliary cirrhosis	0.000225	0.00159	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000224	0.00158	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000224	0.00158	CcSEcCtD
Thalidomide—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000223	0.00157	CcSEcCtD
Thalidomide—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000223	0.00157	CcSEcCtD
Thalidomide—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00156	CcSEcCtD
Thalidomide—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00156	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000219	0.00155	CcSEcCtD
Thalidomide—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00154	CcSEcCtD
Thalidomide—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00154	CcSEcCtD
Thalidomide—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000216	0.00153	CcSEcCtD
Thalidomide—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000216	0.00153	CcSEcCtD
Thalidomide—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000215	0.00152	CcSEcCtD
Thalidomide—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000215	0.00152	CcSEcCtD
Thalidomide—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000212	0.0015	CcSEcCtD
Thalidomide—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000212	0.0015	CcSEcCtD
Thalidomide—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000212	0.0015	CcSEcCtD
Thalidomide—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000212	0.0015	CcSEcCtD
Thalidomide—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000211	0.00149	CcSEcCtD
Thalidomide—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000211	0.00149	CcSEcCtD
Thalidomide—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000211	0.00149	CcSEcCtD
Thalidomide—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000211	0.00149	CcSEcCtD
Thalidomide—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00148	CcSEcCtD
Thalidomide—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00148	CcSEcCtD
Thalidomide—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000209	0.00148	CcSEcCtD
Thalidomide—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000209	0.00148	CcSEcCtD
Thalidomide—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000209	0.00148	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000208	0.00147	CcSEcCtD
Thalidomide—Fatigue—Colchicine—primary biliary cirrhosis	0.000207	0.00146	CcSEcCtD
Thalidomide—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000206	0.00145	CcSEcCtD
Thalidomide—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000206	0.00145	CcSEcCtD
Thalidomide—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000202	0.00143	CcSEcCtD
Thalidomide—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000202	0.00143	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000197	0.00139	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000197	0.00139	CcSEcCtD
Thalidomide—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000197	0.00139	CcSEcCtD
Thalidomide—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000195	0.00138	CcSEcCtD
Thalidomide—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000195	0.00138	CcSEcCtD
Thalidomide—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000194	0.00137	CcSEcCtD
Thalidomide—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000194	0.00137	CcSEcCtD
Thalidomide—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00136	CcSEcCtD
Thalidomide—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00136	CcSEcCtD
Thalidomide—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000192	0.00136	CcSEcCtD
Thalidomide—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000192	0.00136	CcSEcCtD
Thalidomide—Urticaria—Colchicine—primary biliary cirrhosis	0.000191	0.00135	CcSEcCtD
Thalidomide—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00019	0.00134	CcSEcCtD
Thalidomide—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00019	0.00134	CcSEcCtD
Thalidomide—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00019	0.00134	CcSEcCtD
Thalidomide—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000188	0.00133	CcSEcCtD
Thalidomide—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000188	0.00133	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000186	0.00132	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000186	0.00132	CcSEcCtD
Thalidomide—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000186	0.00132	CcSEcCtD
Thalidomide—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000186	0.00132	CcSEcCtD
Thalidomide—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000185	0.0013	CcSEcCtD
Thalidomide—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000185	0.0013	CcSEcCtD
Thalidomide—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000185	0.0013	CcSEcCtD
Thalidomide—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000185	0.0013	CcSEcCtD
Thalidomide—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000178	0.00126	CcSEcCtD
Thalidomide—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000178	0.00126	CcSEcCtD
Thalidomide—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000177	0.00125	CcSEcCtD
Thalidomide—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000177	0.00125	CcSEcCtD
Thalidomide—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000177	0.00125	CcSEcCtD
Thalidomide—Asthenia—Colchicine—primary biliary cirrhosis	0.000172	0.00122	CcSEcCtD
Thalidomide—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000172	0.00121	CcSEcCtD
Thalidomide—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000172	0.00121	CcSEcCtD
Thalidomide—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00121	CcSEcCtD
Thalidomide—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00121	CcSEcCtD
Thalidomide—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00121	CcSEcCtD
Thalidomide—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00121	CcSEcCtD
Thalidomide—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000164	0.00116	CcSEcCtD
Thalidomide—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000159	0.00112	CcSEcCtD
Thalidomide—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000159	0.00112	CcSEcCtD
Thalidomide—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00109	CcSEcCtD
Thalidomide—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00109	CcSEcCtD
Thalidomide—Vomiting—Colchicine—primary biliary cirrhosis	0.000153	0.00108	CcSEcCtD
Thalidomide—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000153	0.00108	CcSEcCtD
Thalidomide—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000153	0.00108	CcSEcCtD
Thalidomide—Rash—Colchicine—primary biliary cirrhosis	0.000152	0.00107	CcSEcCtD
Thalidomide—Dermatitis—Colchicine—primary biliary cirrhosis	0.000151	0.00107	CcSEcCtD
Thalidomide—Headache—Colchicine—primary biliary cirrhosis	0.000151	0.00106	CcSEcCtD
Thalidomide—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000148	0.00104	CcSEcCtD
Thalidomide—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000148	0.00104	CcSEcCtD
Thalidomide—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000143	0.00101	CcSEcCtD
Thalidomide—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000143	0.00101	CcSEcCtD
Thalidomide—Nausea—Colchicine—primary biliary cirrhosis	0.000143	0.00101	CcSEcCtD
Thalidomide—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000137	0.00097	CcSEcCtD
Thalidomide—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000137	0.00097	CcSEcCtD
Thalidomide—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000136	0.000962	CcSEcCtD
Thalidomide—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000136	0.000962	CcSEcCtD
Thalidomide—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000136	0.000961	CcSEcCtD
Thalidomide—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000136	0.000961	CcSEcCtD
Thalidomide—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000135	0.000956	CcSEcCtD
Thalidomide—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000135	0.000956	CcSEcCtD
Thalidomide—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000128	0.000906	CcSEcCtD
Thalidomide—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000128	0.000906	CcSEcCtD
Thalidomide—FGFR2—epithelium—primary biliary cirrhosis	8e-05	0.133	CbGeAlD
Thalidomide—FGFR2—smooth muscle tissue—primary biliary cirrhosis	7.71e-05	0.128	CbGeAlD
Thalidomide—NFKB1—liver—primary biliary cirrhosis	6.04e-05	0.1	CbGeAlD
Thalidomide—CRBN—liver—primary biliary cirrhosis	5.06e-05	0.0842	CbGeAlD
Thalidomide—PTGS2—gall bladder—primary biliary cirrhosis	4.7e-05	0.0782	CbGeAlD
Thalidomide—FGFR2—liver—primary biliary cirrhosis	4.53e-05	0.0754	CbGeAlD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	4.13e-05	0.000417	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—CD80—primary biliary cirrhosis	4.09e-05	0.000413	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CTLA4—primary biliary cirrhosis	4.08e-05	0.000412	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—PPARGC1A—primary biliary cirrhosis	4.03e-05	0.000407	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—ELMO1—primary biliary cirrhosis	3.98e-05	0.000402	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—TAB1—primary biliary cirrhosis	3.98e-05	0.000402	CbGpPWpGaD
Thalidomide—FGFR2—Fc epsilon receptor (FCERI) signaling—NFKB1—primary biliary cirrhosis	3.95e-05	0.000399	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD79A—primary biliary cirrhosis	3.89e-05	0.000393	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CTLA4—primary biliary cirrhosis	3.87e-05	0.000391	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—primary biliary cirrhosis	3.84e-05	0.000388	CbGpPWpGaD
Thalidomide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—primary biliary cirrhosis	3.78e-05	0.000382	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—ELMO1—primary biliary cirrhosis	3.78e-05	0.000382	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—TAB1—primary biliary cirrhosis	3.77e-05	0.000381	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—TYK2—primary biliary cirrhosis	3.7e-05	0.000373	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD79A—primary biliary cirrhosis	3.69e-05	0.000373	CbGpPWpGaD
Thalidomide—FGFR2—B Cell Activation—NFKB1—primary biliary cirrhosis	3.65e-05	0.000369	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by NGF—TYK2—primary biliary cirrhosis	3.64e-05	0.000367	CbGpPWpGaD
Thalidomide—CYP2C19—Biological oxidations—GGT1—primary biliary cirrhosis	3.61e-05	0.000364	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	3.51e-05	0.000354	CbGpPWpGaD
Thalidomide—FGFR2—Disease—ELMO1—primary biliary cirrhosis	3.49e-05	0.000353	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—TYK2—primary biliary cirrhosis	3.45e-05	0.000348	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	3.43e-05	0.000346	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—LBR—primary biliary cirrhosis	3.42e-05	0.000345	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—NUP210—primary biliary cirrhosis	3.41e-05	0.000345	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	3.38e-05	0.000341	CbGpPWpGaD
Thalidomide—TNF—MAPK Signaling Pathway—NFKB1—primary biliary cirrhosis	3.3e-05	0.000334	CbGpPWpGaD
Thalidomide—CYP2C9—Biological oxidations—GGT1—primary biliary cirrhosis	3.29e-05	0.000332	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	3.26e-05	0.000329	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—NUP210—primary biliary cirrhosis	3.24e-05	0.000327	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—LBR—primary biliary cirrhosis	3.22e-05	0.000325	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—LBR—primary biliary cirrhosis	3.21e-05	0.000324	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CDH5—primary biliary cirrhosis	3.19e-05	0.000322	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD40LG—primary biliary cirrhosis	3.17e-05	0.00032	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—OGDH—primary biliary cirrhosis	3.11e-05	0.000314	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	3.08e-05	0.000311	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—PPARGC1A—primary biliary cirrhosis	3.07e-05	0.00031	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCR5—primary biliary cirrhosis	3.07e-05	0.00031	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—LBR—primary biliary cirrhosis	3.03e-05	0.000306	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CDH5—primary biliary cirrhosis	3.02e-05	0.000305	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD40LG—primary biliary cirrhosis	3.01e-05	0.000304	CbGpPWpGaD
Thalidomide—FGFR2—Disease—NUP210—primary biliary cirrhosis	2.99e-05	0.000302	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	2.98e-05	0.000301	CbGpPWpGaD
Thalidomide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—primary biliary cirrhosis	2.94e-05	0.000297	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCR5—primary biliary cirrhosis	2.91e-05	0.000294	CbGpPWpGaD
Thalidomide—CYP1A1—epithelium—primary biliary cirrhosis	2.9e-05	0.0482	CbGeAlD
Thalidomide—CYP1A2—Biological oxidations—GGT1—primary biliary cirrhosis	2.81e-05	0.000284	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.81e-05	0.000283	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL9—primary biliary cirrhosis	2.78e-05	0.000281	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PDHX—primary biliary cirrhosis	2.77e-05	0.00028	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—MMP9—primary biliary cirrhosis	2.74e-05	0.000277	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—NFKB1—primary biliary cirrhosis	2.69e-05	0.000271	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCL9—primary biliary cirrhosis	2.64e-05	0.000267	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	2.63e-05	0.000266	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—DLAT—primary biliary cirrhosis	2.61e-05	0.000263	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ABCB4—primary biliary cirrhosis	2.61e-05	0.000263	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—ELMO1—primary biliary cirrhosis	2.58e-05	0.00026	CbGpPWpGaD
Thalidomide—PTGS1—epithelium—primary biliary cirrhosis	2.54e-05	0.0423	CbGeAlD
Thalidomide—CYP2C19—Metabolism—LBR—primary biliary cirrhosis	2.48e-05	0.000251	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CTLA4—primary biliary cirrhosis	2.47e-05	0.00025	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—OGDH—primary biliary cirrhosis	2.47e-05	0.000249	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—MMP2—primary biliary cirrhosis	2.46e-05	0.000248	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—CD80—primary biliary cirrhosis	2.46e-05	0.000248	CbGpPWpGaD
Thalidomide—PTGS1—smooth muscle tissue—primary biliary cirrhosis	2.45e-05	0.0408	CbGeAlD
Thalidomide—FGFR2—Signaling Pathways—ELMO1—primary biliary cirrhosis	2.44e-05	0.000247	CbGpPWpGaD
Thalidomide—PTGS2—epithelium—primary biliary cirrhosis	2.43e-05	0.0404	CbGeAlD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.4e-05	0.000243	CbGpPWpGaD
Thalidomide—FGFR2—Disease—GOT2—primary biliary cirrhosis	2.36e-05	0.000239	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD79A—primary biliary cirrhosis	2.36e-05	0.000238	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD80—primary biliary cirrhosis	2.36e-05	0.000238	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—TYK2—primary biliary cirrhosis	2.35e-05	0.000237	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CTLA4—primary biliary cirrhosis	2.35e-05	0.000237	CbGpPWpGaD
Thalidomide—PTGS2—smooth muscle tissue—primary biliary cirrhosis	2.34e-05	0.039	CbGeAlD
Thalidomide—FGFR2—Innate Immune System—CD80—primary biliary cirrhosis	2.33e-05	0.000235	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—OGDH—primary biliary cirrhosis	2.33e-05	0.000235	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—OGDH—primary biliary cirrhosis	2.32e-05	0.000234	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—TAB1—primary biliary cirrhosis	2.32e-05	0.000234	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—LBR—primary biliary cirrhosis	2.26e-05	0.000229	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD79A—primary biliary cirrhosis	2.24e-05	0.000226	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD80—primary biliary cirrhosis	2.24e-05	0.000226	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.23e-05	0.000225	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PDHX—primary biliary cirrhosis	2.2e-05	0.000222	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—TAB1—primary biliary cirrhosis	2.2e-05	0.000222	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—OGDH—primary biliary cirrhosis	2.19e-05	0.000221	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.14e-05	0.000216	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—TYK2—primary biliary cirrhosis	2.07e-05	0.000209	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PDHX—primary biliary cirrhosis	2.07e-05	0.000209	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ABCB4—primary biliary cirrhosis	2.07e-05	0.000209	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—DLAT—primary biliary cirrhosis	2.07e-05	0.000209	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PDHX—primary biliary cirrhosis	2.07e-05	0.000209	CbGpPWpGaD
Thalidomide—FGFR2—Disease—GOT1—primary biliary cirrhosis	2.04e-05	0.000206	CbGpPWpGaD
Thalidomide—CYP2C19—liver—primary biliary cirrhosis	2.04e-05	0.0339	CbGeAlD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.98e-05	0.0002	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—TYK2—primary biliary cirrhosis	1.97e-05	0.000199	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PDHX—primary biliary cirrhosis	1.95e-05	0.000197	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—DLAT—primary biliary cirrhosis	1.95e-05	0.000197	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ABCB4—primary biliary cirrhosis	1.95e-05	0.000197	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ABCB4—primary biliary cirrhosis	1.94e-05	0.000196	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—DLAT—primary biliary cirrhosis	1.94e-05	0.000196	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	1.93e-05	0.000195	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD40LG—primary biliary cirrhosis	1.92e-05	0.000194	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.91e-05	0.000193	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—MMP2—primary biliary cirrhosis	1.87e-05	0.000189	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—MMP9—primary biliary cirrhosis	1.85e-05	0.000187	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	1.84e-05	0.000186	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—DLAT—primary biliary cirrhosis	1.84e-05	0.000186	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ABCB4—primary biliary cirrhosis	1.84e-05	0.000186	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD40LG—primary biliary cirrhosis	1.82e-05	0.000184	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—OGDH—primary biliary cirrhosis	1.79e-05	0.000181	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—TYK2—primary biliary cirrhosis	1.79e-05	0.000181	CbGpPWpGaD
Thalidomide—PTGS2—Disease—ELMO1—primary biliary cirrhosis	1.73e-05	0.000175	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.7e-05	0.000171	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.69e-05	0.000171	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.66e-05	0.000168	CbGpPWpGaD
Thalidomide—CYP1A2—liver—primary biliary cirrhosis	1.66e-05	0.0277	CbGeAlD
Thalidomide—CYP1A1—liver—primary biliary cirrhosis	1.64e-05	0.0273	CbGeAlD
Thalidomide—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	1.64e-05	0.000165	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.62e-05	0.000163	CbGpPWpGaD
Thalidomide—CYP3A5—liver—primary biliary cirrhosis	1.6e-05	0.0267	CbGeAlD
Thalidomide—CYP2C19—Metabolism—PDHX—primary biliary cirrhosis	1.6e-05	0.000162	CbGpPWpGaD
Thalidomide—CYP2C9—liver—primary biliary cirrhosis	1.58e-05	0.0263	CbGeAlD
Thalidomide—PTGS1—Metabolism—NUP210—primary biliary cirrhosis	1.57e-05	0.000158	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—NFKB1—primary biliary cirrhosis	1.53e-05	0.000155	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.51e-05	0.000152	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—DLAT—primary biliary cirrhosis	1.5e-05	0.000152	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ABCB4—primary biliary cirrhosis	1.5e-05	0.000152	CbGpPWpGaD
Thalidomide—CYP2E1—liver—primary biliary cirrhosis	1.5e-05	0.0249	CbGeAlD
Thalidomide—PTGS2—Disease—NUP210—primary biliary cirrhosis	1.49e-05	0.00015	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.48e-05	0.000149	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.47e-05	0.000149	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	1.46e-05	0.000147	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ABCG2—primary biliary cirrhosis	1.46e-05	0.000147	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.45e-05	0.000146	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD80—primary biliary cirrhosis	1.43e-05	0.000145	CbGpPWpGaD
Thalidomide—FGFR2—Disease—HIF1A—primary biliary cirrhosis	1.42e-05	0.000143	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—MMP9—primary biliary cirrhosis	1.41e-05	0.000142	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	1.4e-05	0.000141	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—NFKB1—primary biliary cirrhosis	1.39e-05	0.000141	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.38e-05	0.00014	CbGpPWpGaD
Thalidomide—PTGS2—liver—primary biliary cirrhosis	1.38e-05	0.0229	CbGeAlD
Thalidomide—FGFR2—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.38e-05	0.000139	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	1.37e-05	0.000138	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	1.37e-05	0.000138	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD80—primary biliary cirrhosis	1.36e-05	0.000137	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MMP3—primary biliary cirrhosis	1.32e-05	0.000134	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.32e-05	0.000133	CbGpPWpGaD
Thalidomide—FGFR2—Disease—NOS2—primary biliary cirrhosis	1.29e-05	0.00013	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.28e-05	0.000129	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.26e-05	0.000127	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.26e-05	0.000127	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MMP3—primary biliary cirrhosis	1.25e-05	0.000127	CbGpPWpGaD
Thalidomide—FGFR2—Disease—CD80—primary biliary cirrhosis	1.25e-05	0.000127	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—CTGF—primary biliary cirrhosis	1.25e-05	0.000126	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CCL5—primary biliary cirrhosis	1.25e-05	0.000126	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	1.25e-05	0.000126	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—NUP210—primary biliary cirrhosis	1.24e-05	0.000126	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—GOT2—primary biliary cirrhosis	1.24e-05	0.000125	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.23e-05	0.000124	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.21e-05	0.000122	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—TYK2—primary biliary cirrhosis	1.21e-05	0.000122	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CCL5—primary biliary cirrhosis	1.18e-05	0.00012	CbGpPWpGaD
Thalidomide—PTGS2—Disease—GOT2—primary biliary cirrhosis	1.17e-05	0.000119	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.17e-05	0.000118	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	1.17e-05	0.000118	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	1.17e-05	0.000118	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—NUP210—primary biliary cirrhosis	1.17e-05	0.000118	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—NUP210—primary biliary cirrhosis	1.17e-05	0.000118	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ABCG2—primary biliary cirrhosis	1.16e-05	0.000117	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.15e-05	0.000116	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—TYK2—primary biliary cirrhosis	1.15e-05	0.000116	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.12e-05	0.000113	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—NUP210—primary biliary cirrhosis	1.1e-05	0.000112	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ABCG2—primary biliary cirrhosis	1.09e-05	0.00011	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ABCG2—primary biliary cirrhosis	1.09e-05	0.00011	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.08e-05	0.000109	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—GOT1—primary biliary cirrhosis	1.07e-05	0.000108	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—GGT1—primary biliary cirrhosis	1.07e-05	0.000108	CbGpPWpGaD
Thalidomide—FGFR2—Disease—TYK2—primary biliary cirrhosis	1.06e-05	0.000107	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.05e-05	0.000106	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—AGT—primary biliary cirrhosis	1.04e-05	0.000105	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ABCG2—primary biliary cirrhosis	1.03e-05	0.000104	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.01e-05	0.000102	CbGpPWpGaD
Thalidomide—PTGS2—Disease—GOT1—primary biliary cirrhosis	1.01e-05	0.000102	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—HIF1A—primary biliary cirrhosis	9.94e-06	0.0001	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CTGF—primary biliary cirrhosis	9.92e-06	0.0001	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—AGT—primary biliary cirrhosis	9.91e-06	0.0001	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—GOT2—primary biliary cirrhosis	9.83e-06	9.93e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	9.6e-06	9.7e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	9.6e-06	9.69e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PPARGC1A—primary biliary cirrhosis	9.52e-06	9.61e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CTGF—primary biliary cirrhosis	9.34e-06	9.43e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CTGF—primary biliary cirrhosis	9.32e-06	9.42e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—GOT2—primary biliary cirrhosis	9.26e-06	9.35e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CD80—primary biliary cirrhosis	9.25e-06	9.34e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—GOT2—primary biliary cirrhosis	9.24e-06	9.33e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—NUP210—primary biliary cirrhosis	9.04e-06	9.13e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	9e-06	9.09e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—NFKB1—primary biliary cirrhosis	8.93e-06	9.02e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CTGF—primary biliary cirrhosis	8.81e-06	8.89e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CD80—primary biliary cirrhosis	8.78e-06	8.86e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	8.75e-06	8.84e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—GOT2—primary biliary cirrhosis	8.73e-06	8.82e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—GGT1—primary biliary cirrhosis	8.49e-06	8.57e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—GOT1—primary biliary cirrhosis	8.49e-06	8.57e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ABCG2—primary biliary cirrhosis	8.4e-06	8.48e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	8.24e-06	8.32e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—GOT1—primary biliary cirrhosis	7.99e-06	8.07e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—GGT1—primary biliary cirrhosis	7.99e-06	8.07e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—GGT1—primary biliary cirrhosis	7.97e-06	8.05e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—GOT1—primary biliary cirrhosis	7.97e-06	8.05e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TYK2—primary biliary cirrhosis	7.81e-06	7.89e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	7.66e-06	7.74e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PPARGC1A—primary biliary cirrhosis	7.55e-06	7.63e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—GGT1—primary biliary cirrhosis	7.53e-06	7.61e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—GOT1—primary biliary cirrhosis	7.53e-06	7.61e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	7.48e-06	7.55e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—AGT—primary biliary cirrhosis	7.41e-06	7.49e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TYK2—primary biliary cirrhosis	7.41e-06	7.48e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	7.36e-06	7.44e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CTGF—primary biliary cirrhosis	7.21e-06	7.28e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—GOT2—primary biliary cirrhosis	7.14e-06	7.21e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PPARGC1A—primary biliary cirrhosis	7.11e-06	7.18e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PPARGC1A—primary biliary cirrhosis	7.1e-06	7.17e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—HIF1A—primary biliary cirrhosis	7.05e-06	7.12e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	7.04e-06	7.11e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	6.71e-06	6.78e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PPARGC1A—primary biliary cirrhosis	6.7e-06	6.77e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	6.57e-06	6.64e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	6.55e-06	6.61e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	6.51e-06	6.58e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NOS2—primary biliary cirrhosis	6.42e-06	6.48e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CD80—primary biliary cirrhosis	6.22e-06	6.29e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—GOT1—primary biliary cirrhosis	6.17e-06	6.23e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—GGT1—primary biliary cirrhosis	6.17e-06	6.23e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MMP9—primary biliary cirrhosis	6.15e-06	6.21e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—AGT—primary biliary cirrhosis	5.88e-06	5.94e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MMP9—primary biliary cirrhosis	5.83e-06	5.89e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—NFKB1—primary biliary cirrhosis	5.77e-06	5.83e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	5.74e-06	5.8e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ALB—primary biliary cirrhosis	5.69e-06	5.74e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	5.62e-06	5.68e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	5.62e-06	5.68e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	5.62e-06	5.67e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	5.57e-06	5.62e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—AGT—primary biliary cirrhosis	5.54e-06	5.59e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—AGT—primary biliary cirrhosis	5.53e-06	5.58e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PPARGC1A—primary biliary cirrhosis	5.49e-06	5.54e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—TYK2—primary biliary cirrhosis	5.25e-06	5.31e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—AGT—primary biliary cirrhosis	5.22e-06	5.27e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	5e-06	5.05e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	4.8e-06	4.85e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	4.8e-06	4.85e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ALB—primary biliary cirrhosis	4.52e-06	4.56e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	4.28e-06	4.32e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—AGT—primary biliary cirrhosis	4.27e-06	4.32e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ALB—primary biliary cirrhosis	4.25e-06	4.29e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ALB—primary biliary cirrhosis	4.24e-06	4.28e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ALB—primary biliary cirrhosis	4.01e-06	4.05e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	3.9e-06	3.94e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	3.33e-06	3.36e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ALB—primary biliary cirrhosis	3.28e-06	3.31e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	2.99e-06	3.02e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	2.56e-06	2.58e-05	CbGpPWpGaD
